Works about ENTRESTO
Results: 277
Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic Drugs.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 230, doi. 10.3390/ph18020230
- By:
- Publication type:
- Article
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 505, doi. 10.1007/s10557-022-07421-0
- By:
- Publication type:
- Article
Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 3, p. 549, doi. 10.1007/s10557-022-07315-1
- By:
- Publication type:
- Article
Five Years of Sacubitril/Valsartan—a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 5, p. 915, doi. 10.1007/s10557-021-07210-1
- By:
- Publication type:
- Article
Association Between Albumin-Bilirubin Score and Ventricular Arrhythmia in Patients with Heart Failure.
- Published in:
- E Journal of Cardiovascular Medicine, 2024, v. 12, n. 1, p. 17, doi. 10.32596/ejcm.galenos.2024.2024-6-60
- By:
- Publication type:
- Article
沙库巴曲缬沙坦钠对老年慢性心力衰竭合并2型糖尿病患者肾功能、神经内分泌激素和TGF-β1/Smad3信号通路的影响.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 16, p. 3102, doi. 10.13241/j.cnki.pmb.2023.16.020
- By:
- Publication type:
- Article
IMPACT OF LOW-DOSE SACUBITRIL-VALSARTAN ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION.
- Published in:
- Pakistan Heart Journal, 2022, v. 55, p. S6, doi. 10.47144/phj.v55iSupplement1.2422
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan in patients with left ventricular assist devices: Case series.
- Published in:
- Artificial Organs, 2021, v. 45, n. 2, p. 185, doi. 10.1111/aor.13796
- By:
- Publication type:
- Article
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS).
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-79272-8
- By:
- Publication type:
- Article
Subgroup disproportionality analysis of dementia-related adverse events with sacubitril/valsartan across geographical regions.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67050-5
- By:
- Publication type:
- Article
Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1187, doi. 10.1007/s40273-022-01182-2
- By:
- Publication type:
- Article
Assessment of Ultra-Early Administration of Sacubitril Valsartan to Improve Cardiac Remodeling in Patients With Acute Myocardial Infarction Following Primary PCI: Rational and Design of a Prospective, Multicenter, Randomized Controlled Trial.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.831212
- By:
- Publication type:
- Article
Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.652163
- By:
- Publication type:
- Article
A Simple Score to Identify Super-Responders to Sacubitril/Valsartan in Ambulatory Patients With Heart Failure.
- Published in:
- Frontiers in Physiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphys.2021.642117
- By:
- Publication type:
- Article
Heart Failure with Preserved Ejection Fraction: An Enigma.
- Published in:
- Indian Journal of Public Health Research & Development, 2023, v. 14, n. 1, p. 70, doi. 10.37506/ijphrd.v14i1.18795
- By:
- Publication type:
- Article
In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0228926
- By:
- Publication type:
- Article
The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse Model.
- Published in:
- Inflammation, 2024, v. 47, n. 2, p. 696, doi. 10.1007/s10753-023-01939-7
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01545-1
- By:
- Publication type:
- Article
Natriuretic peptides-alternative pathways for the activation of intracellular signaling axis-cyclic guanylyl-monophosphate-protein kinase G at the background of preserved ejection fraction during chronic heart failure.
- Published in:
- Translational & Clinical Medicine - Georgian Medical Journal, 2024, v. 9, n. 2, p. 60
- By:
- Publication type:
- Article
Angiotensin receptor-neprilysin inhibition in acute myocardial infarction.
- Published in:
- Cardiology Research Review, 2021, n. 97, p. 6
- Publication type:
- Article
Guideline-Optimised Treatment in Heart Failure—Do Higher Doses Reduce Systemic Inflammation More Significantly?
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 11, p. 3056, doi. 10.3390/jcm13113056
- By:
- Publication type:
- Article
The Efficacy and Safety of Sacubitril/Valsartan Compared to Valsartan in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fractions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1572, doi. 10.3390/jcm13061572
- By:
- Publication type:
- Article
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6247, doi. 10.3390/jcm12196247
- By:
- Publication type:
- Article
Long-Term Effects of Sacubitril-Valsartan on Cardiac Remodeling: A Parallel Echocardiographic Study of Left and Right Heart Adaptive Response.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2659, doi. 10.3390/jcm12072659
- By:
- Publication type:
- Article
Effectiveness and Safety of Sacubitril/Valsartan in Patients with Chronic Kidney Disease—A Real-World Experience.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1334, doi. 10.3390/jcm12041334
- By:
- Publication type:
- Article
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 1086, doi. 10.3390/jcm12031086
- By:
- Publication type:
- Article
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study).
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 699, doi. 10.3390/jcm12020699
- By:
- Publication type:
- Article
Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 621, doi. 10.3390/jcm12020621
- By:
- Publication type:
- Article
Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5199, doi. 10.3390/jcm11175199
- By:
- Publication type:
- Article
Effects of Sacubitril/Valsartan on the Renal Resistance Index.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 13, p. 3683, doi. 10.3390/jcm11133683
- By:
- Publication type:
- Article
Sacubitril/Valsartan in the Treatment of Resistant Hypertension: Raising Star or Illusion?
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3081, doi. 10.3390/jcm11113081
- By:
- Publication type:
- Article
The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1111, doi. 10.3390/jcm9041111
- By:
- Publication type:
- Article
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 906, doi. 10.3390/jcm9040906
- By:
- Publication type:
- Article
The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The "Hemodynamic Recovery".
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2165, doi. 10.3390/jcm8122165
- By:
- Publication type:
- Article
Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1582, doi. 10.3390/jcm8101582
- By:
- Publication type:
- Article
Sacubitril/valsartan, sodium‐glucose cotransporter 2 inhibitors and vericiguat for congestive heart failure therapy.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 425, doi. 10.1111/bcpt.13714
- By:
- Publication type:
- Article
LCZ696 (Valsartan/Sacubitril) - A Possible New Treatment for Hypertension and Heart Failure.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2016, v. 118, n. 1, p. 14, doi. 10.1111/bcpt.12453
- By:
- Publication type:
- Article
Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 733, doi. 10.3390/biomedicines12040733
- By:
- Publication type:
- Article
Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure.
- Published in:
- Biomedicines, 2023, v. 11, n. 4, p. 1037, doi. 10.3390/biomedicines11041037
- By:
- Publication type:
- Article
The Role of NF-κB and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease.
- Published in:
- Biomedicines, 2022, v. 10, n. 11, p. 2863, doi. 10.3390/biomedicines10112863
- By:
- Publication type:
- Article
Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081844
- By:
- Publication type:
- Article
Application of Continuous Wavelet Transform Coupled with Zero-crossing Technique for the Simultaneous Spectrophotometric Determination of Sacubitril and Valsartan in Tablet Dosage Form.
- Published in:
- Journal of Chemical Health Risks, 2019, v. 9, n. 4, p. 331, doi. 10.22034/jchr.2019.669349
- By:
- Publication type:
- Article
A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1392263
- By:
- Publication type:
- Article
Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock.
- Published in:
- Case Reports in Cardiology, 2018, p. 1, doi. 10.1155/2018/8231576
- By:
- Publication type:
- Article
ISOLATION AND STRUCTURAL ELUCIDATION OF SACUBITRIL SODIUM DEGRADATION PRODUCTS BY MASS AND NMR SPECTROSCOPY.
- Published in:
- Rasayan Journal of Chemistry, 2022, v. 15, n. 2, p. 1567, doi. 10.31788/RJC.2022.1526456
- By:
- Publication type:
- Article
Sacubitril/Valsartan Improves Progression of Early Diabetic Nephropathy in Rats Through Inhibition of NLRP3 Inflammasome Pathway.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 2479, doi. 10.2147/DMSO.S366518
- By:
- Publication type:
- Article
Comparative Efficacy of Curative Effects of Sacubitril/Valsartan in HFpEF versus HFrEF Treatment.
- Published in:
- Alternative Therapies in Health & Medicine, 2024, v. 30, n. 11, p. 450
- By:
- Publication type:
- Article
Effectiveness and Safety of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
- Published in:
- Alternative Therapies in Health & Medicine, 2024, v. 30, n. 4, p. 190
- By:
- Publication type:
- Article
Insuficiencia cardíaca crónica en Argentina. OFFICE IC AR, un registro conjunto de la Sociedad Argentina de Cardiología y de la Federación Argentina de Cardiología.
- Published in:
- Revista Argentina de Cardiología, 2022, v. 90, n. 1, p. 15, doi. 10.7775/rac.es.v90.i1.20480
- By:
- Publication type:
- Article
Correction to: Outcomes of Heart Failure with Reduced Ejection Fraction Patients Receiving Sacubitril/Valsartan in Real-World Practice.
- Published in:
- Journal of the Medical Association of Thailand, 2022, v. 105, n. 12, p. 1304, doi. 10.35755/jmedassocthai.2022.12.13725
- Publication type:
- Article